Literature DB >> 18332838

Impulse control disorders and pathological gambling in patients with Parkinson disease.

William Stamey1, Joseph Jankovic.   

Abstract

OBJECTIVES: The primary aim of this article is to critically review the clinical features and comorbidities, epidemiology, pathophysiology, and treatment of impulse control disorder (ICD) associated with Parkinson disease (PD).
METHODS: References for this review were identified by searches of PubMed from 1980 until January 2008 with the terms "Parkinson disease," "impulse control," "pathologic gambling,""hypersexuality," "levodopa," and "dopamine agonists." Articles were also identified through searches of the authors' own files. Only papers published in English were reviewed.
RESULTS: Pathologic gambling has emerged as one of the most prominent ICDs, although hypersexuality, compulsive shopping and other manifestations of obsessive-compulsive disorder may also dominate PD-related behavioral manifestations. Affected patients may demonstrate a pattern of self-escalation of dopaminergic medication dosing which may lead to a state of dependency.
CONCLUSIONS: Patients most commonly affected by ICD, such as pathologic gambling and hypersexuality, are males who develop PD at a younger age, and those with a previous history of mood disorder, alcohol abuse, or obsessive-compulsive disorder. Dopaminergic drugs, particularly dopamine agonists, play an important role in triggering these nonmotor symptoms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332838     DOI: 10.1097/NRL.0b013e31816606a7

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  12 in total

1.  Attempted suicide under high dose dopaminergic therapy including apomorphine.

Authors:  Walter Struhal; Michael Guger; Stephanie Hödl; Sok-Chu Ung; Michael Bach; Gerhard Ransmayr
Journal:  Wien Klin Wochenschr       Date:  2012-07-15       Impact factor: 1.704

2.  Sleep alterations in an environmental neurotoxin-induced model of parkinsonism.

Authors:  Kimberly A McDowell; Maria M Hadjimarkou; Shaun Viechweg; Avigail E Rose; Sarah M Clark; Paul J Yarowsky; Jessica A Mong
Journal:  Exp Neurol       Date:  2010-08-14       Impact factor: 5.330

3.  Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study.

Authors:  Jason R Cornelius; Maja Tippmann-Peikert; Nancy L Slocumb; Courtney F Frerichs; Michael H Silber
Journal:  Sleep       Date:  2010-01       Impact factor: 5.849

4.  Evaluation and management of the non-motor features of Parkinson's disease.

Authors:  Steven Wishart; Graeme J A Macphee
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

Review 5.  MicroRNA implications across neurodevelopment and neuropathology.

Authors:  Sabata Martino; Ilaria di Girolamo; Antonio Orlacchio; Alessandro Datti; Aldo Orlacchio
Journal:  J Biomed Biotechnol       Date:  2009-10-13

6.  Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease.

Authors:  Howard D Weiss; Laura Marsh
Journal:  Neurol Clin Pract       Date:  2012-12

7.  Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.

Authors:  J Michael Bostwick; Kathleen A Hecksel; Susanna R Stevens; James H Bower; J Eric Ahlskog
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

8.  Impulse control disorders in Parkinson's disease: a psychosocial perspective.

Authors:  Mary Delaney; Iracema Leroi; Jane Simpson; Paul Geoffrey Overton
Journal:  J Clin Psychol Med Settings       Date:  2012-09

Review 9.  Implications of dopaminergic medication withdrawal in Parkinson's disease.

Authors:  J Koschel; K Ray Chaudhuri; L Tönges; M Thiel; V Raeder; W H Jost
Journal:  J Neural Transm (Vienna)       Date:  2021-07-29       Impact factor: 3.850

10.  Untangling Cortico-Striatal Connectivity and Cross-Frequency Coupling in L-DOPA-Induced Dyskinesia.

Authors:  Jovana J Belić; Pär Halje; Ulrike Richter; Per Petersson; Jeanette Hellgren Kotaleski
Journal:  Front Syst Neurosci       Date:  2016-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.